Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

High dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial.

Schnoll RA, Wileyto EP, Leone FT, Tyndale RF, Benowitz NL.

Nicotine Tob Res. 2013 Feb;15(2):348-54. doi: 10.1093/ntr/nts129. Epub 2012 May 15.

PMID:
22589423
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.

Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR.

JAMA. 1995 Nov 1;274(17):1353-8.

PMID:
7563559
[PubMed - indexed for MEDLINE]
3.

Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study.

Schnoll RA, Patterson F, Wileyto EP, Tyndale RF, Benowitz N, Lerman C.

Pharmacol Biochem Behav. 2009 Mar;92(1):6-11. doi: 10.1016/j.pbb.2008.10.016. Epub 2008 Oct 31.

PMID:
19000709
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Varying nicotine patch dose and type of smoking cessation counseling.

Jorenby DE, Smith SS, Fiore MC, Hurt RD, Offord KP, Croghan IT, Hays JT, Lewis SF, Baker TB.

JAMA. 1995 Nov 1;274(17):1347-52.

PMID:
7563558
[PubMed - indexed for MEDLINE]
5.

Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.

Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP, Lauger GG, Marŭsić Z, Neese LW, Lundberg TG.

JAMA. 1994 Feb 23;271(8):595-600.

PMID:
8301791
[PubMed - indexed for MEDLINE]
6.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
[PubMed - indexed for MEDLINE]
7.

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial.

Schnoll RA, Patterson F, Wileyto EP, Heitjan DF, Shields AE, Asch DA, Lerman C.

Ann Intern Med. 2010 Feb 2;152(3):144-51. doi: 10.7326/0003-4819-152-3-201002020-00005.

PMID:
20124230
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels.

Fredrickson PA, Hurt RD, Lee GM, Wingender L, Croghan IT, Lauger G, Gomez-Dahl L, Offord KP.

Psychopharmacology (Berl). 1995 Dec;122(3):215-22.

PMID:
8748390
[PubMed - indexed for MEDLINE]
9.

Nicotine patch therapy in adolescent smokers.

Smith TA, House RF Jr, Croghan IT, Gauvin TR, Colligan RC, Offord KP, Gomez-Dahl LC, Hurt RD.

Pediatrics. 1996 Oct;98(4 Pt 1):659-67.

PMID:
8885942
[PubMed - indexed for MEDLINE]
10.

Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.

Lerman C, Tyndale R, Patterson F, Wileyto EP, Shields PG, Pinto A, Benowitz N.

Clin Pharmacol Ther. 2006 Jun;79(6):600-8. Epub 2006 May 11.

PMID:
16765148
[PubMed - indexed for MEDLINE]
11.

Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.

Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G.

Prev Med. 1995 Jan;24(1):41-7.

PMID:
7740014
[PubMed - indexed for MEDLINE]
12.

Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.

Hurt RD, Croghan GA, Beede SD, Wolter TD, Croghan IT, Patten CA.

Arch Pediatr Adolesc Med. 2000 Jan;154(1):31-7.

PMID:
10632247
[PubMed - indexed for MEDLINE]
13.

Predicting smoking cessation. Who will quit with and without the nicotine patch.

Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB.

JAMA. 1994 Feb 23;271(8):589-94.

PMID:
8301790
[PubMed - indexed for MEDLINE]
14.

Treating nondepressed smokers with alcohol dependence in sustained full remission: nicotine patch therapy tailored to baseline serum cotinine.

Hurt RD, Patten CA, Offord KP, Croghan IT, Decker PA, Morris RA, Hays JT.

J Stud Alcohol. 2005 Jul;66(4):506-16.

PMID:
16240558
[PubMed - indexed for MEDLINE]
15.

Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.

Moolchan ET, Robinson ML, Ernst M, Cadet JL, Pickworth WB, Heishman SJ, Schroeder JR.

Pediatrics. 2005 Apr;115(4):e407-14.

PMID:
15805342
[PubMed - indexed for MEDLINE]
16.

Triple-combination pharmacotherapy for medically ill smokers: a randomized trial.

Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL.

Ann Intern Med. 2009 Apr 7;150(7):447-54.

PMID:
19349630
[PubMed - indexed for MEDLINE]
17.

The transdermal nicotine patch: results of a randomised placebo-controlled trial.

Richmond RL, Harris K, de Almeida Neto A.

Med J Aust. 1994 Jul 18;161(2):130-5.

PMID:
8028537
[PubMed - indexed for MEDLINE]
18.
19.

Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.

Shiffman S, Sweeney CT, Ferguson SG, Sembower MA, Gitchell JG.

Clin Ther. 2008 Oct;30(10):1852-8. doi: 10.1016/j.clinthera.2008.09.016.

PMID:
19014840
[PubMed - indexed for MEDLINE]
20.

Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers.

Rubinstein ML, Benowitz NL, Auerback GM, Moscicki AB.

Pediatrics. 2008 Sep;122(3):e643-7. doi: 10.1542/peds.2007-3679.

PMID:
18762498
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk